Posted in | News | Medical Sensor

Clinical Results Support Efficacy of EarlySense Contact-Free Patient Monitoring System

EarlySense has declared the results of a post regulatory approval clinical and non-interventional prospective study that enables validating the efficacy of the EarlySense contact-free patient monitoring system for precisely detecting patient deterioration.

The clinical study data will be presented in an article titled ‘Early recognition of acutely deteriorating patients in non-intensive care units: Assessment of an innovative monitoring technology’, which will appear in the October 2012 print edition of the Journal of Hospital Medicine.

With in-built sensor, the EarlySense System can be placed contact-free under the mattress of the patient’s bed. The system has been designed to ensure early detection of patient’s deterioration by constantly monitoring and tracking the health factor signs such as respiratory rate, bed exits and entries, heart rate, and movement. The technology has been fabricated to examine non-ICU ‘lower risk’ patients on medical surgical floors who used to be monitored every five hours by on-duty nurses. Alteration in a patient’s status will enable the system to signal the on-duty nurses at the central nursing station, where the alerts will appear on large screens on their handheld devices or on their department’s wall. The real time delivery of actionable data from EarlySense, when equipped with comprehensive unit management tools, enables the medical professionals to achieve early detection of critical situations with proactive response.

The clinical study was conducted in two various medical departments at two different academic medical centers. The predicting deterioration in terms of sensitivity and specificity were 82% and 67%, respectively for HR and 64% and 81%, respectively for RR. The sensitivity and specificity for trend alerts was found to be 100% and 64% for RR, and 78% and 90% for HR, respectively.

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    EarlySense. (2019, February 24). Clinical Results Support Efficacy of EarlySense Contact-Free Patient Monitoring System. AZoSensors. Retrieved on November 23, 2024 from https://www.azosensors.com/news.aspx?newsID=4762.

  • MLA

    EarlySense. "Clinical Results Support Efficacy of EarlySense Contact-Free Patient Monitoring System". AZoSensors. 23 November 2024. <https://www.azosensors.com/news.aspx?newsID=4762>.

  • Chicago

    EarlySense. "Clinical Results Support Efficacy of EarlySense Contact-Free Patient Monitoring System". AZoSensors. https://www.azosensors.com/news.aspx?newsID=4762. (accessed November 23, 2024).

  • Harvard

    EarlySense. 2019. Clinical Results Support Efficacy of EarlySense Contact-Free Patient Monitoring System. AZoSensors, viewed 23 November 2024, https://www.azosensors.com/news.aspx?newsID=4762.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.